Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why clinicians should be interested in interleukin-3.

P Valent1, K Geissler, C Sillaber

  • 1I. Medical Department, University of Vienna, Austria.

Blut
|December 1, 1990
PubMed
Summary

Interleukin-3 (IL-3) is a novel hematopoietic growth factor that supports stem cell differentiation and myeloid cell maturation. Its broad therapeutic potential includes treating cytopenias, leukemias, and aiding stem cell transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and potential associations of the 2022 newly introduced monocyte value for diagnosis of chronic myelomonocytic leukemia in a general Austrian population.

Wiener medizinische Wochenschrift (1946)·2026
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Laryngo- rhino- otologie·2018
Same author

Laryngo- rhino- otologie·2018
Same author

Differential regulation of PD-1 and its ligands in allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Interleukin-3 (IL-3) is a cytokine produced by activated immune cells.
  • IL-3 has a broad spectrum of biological targets, including various hematopoietic progenitor and stem cells.
  • IL-3 plays a role in the growth, differentiation, and functional enhancement of myeloid cells.

Purpose of the Study:

  • To explore the biological effects and therapeutic potential of Interleukin-3 (IL-3).
  • To evaluate IL-3's role in hematopoietic stem cell differentiation and myeloid cell maturation.
  • To assess IL-3's impact on leukemic cells and its potential in cancer therapy.

Main Methods:

  • Preclinical and clinical trials involving IL-3 administration.
  • Analysis of IL-3's effects on progenitor cells, including CFU-blast.

Related Experiment Videos

  • Investigation of synergistic effects with other myelopoietic cytokines.
  • Assessment of in vivo effects on peripheral white blood cell counts and circulating progenitor cells.

    • Main Results:

    • IL-3 supports the growth of primitive hematopoietic progenitors (CFU-blast) and various stages of stem cell differentiation.
    • Sequential use of IL-3 with other cytokines enhances myeloid cell growth.
    • IL-3 prolongs survival and enhances functional properties of myeloid cells.
    • In vivo IL-3 administration increases peripheral white blood cells and circulating progenitor cells.
    • IL-3 regulates leukemic cell growth and sensitizes them to cytotoxic drugs.

    Conclusions:

    • IL-3 is a unique hematopoietic growth factor with broad clinical applications.
    • IL-3 offers novel therapeutic strategies for cytopenias, leukemic diseases, and stem cell transplantation.
    • Further clinical use of IL-3 is warranted for various hematological conditions.